Status | Study |
Completed |
Study Name: PAD. ICORG 05-01, V11 Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-12-24 Interventions: Drug: Bortezomib Drug: Doxorubicin |
Completed |
Study Name: Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-12-04 Interventions: Biological: anti-thymocyte globulin Drug: |
Active, not recruiting |
Study Name: Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-10-12 Interventions: Drug: dexamethasone |
Active, not recruiting |
Study Name: High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-09-04 Interventions: Drug: cyclophosphamide Given o |
Terminated |
Study Name: Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-08-29 Interventions: Drug: bortezomib Intravenous P |
Terminated |
Study Name: Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-08-26 Interventions: Drug: bortezomib Drug: dexamethasone |
Terminated |
Study Name: Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-05-30 Interventions: Drug: dexamethasone 20 mg oral |
Terminated |
Study Name: High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-03-14 Interventions: Drug: melphalan Procedure: autologous hema |
Completed |
Study Name: Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-03-12 Interventions: Biological: Anakinra (IL-1Ra) |
Terminated |
Study Name: Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2008-03-12 Interventions: Biological: anti-thymocyte globulin |